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Abstract
Genomic imprinting is a form of epigenetic gene regulation that results in expression from a single
allele in a parent-of-origin-dependent manner. This form of monoallelic expression affects a small
but growing number of genes and is essential to normal mammalian development. Despite extensive
studies and some major breakthroughs regarding this intriguing phenomenon, we have not yet fully
characterized the underlying molecular mechanisms of genomic imprinting. This is in part due to the
complexity of the system in that the epigenetic markings required for proper imprinting must be
established in the germline, maintained throughout development, and then erased before being re-
established in the next generation’s germline. Furthermore, imprinted gene expression is often tissue
or stage-specific. It has also become clear that while imprinted loci across the genome seem to rely
consistently on epigenetic markings of DNA methylation and/or histone modifications to discern
parental alleles, the regulatory activities underlying these markings vary among loci. Here, we discuss
different modes of imprinting regulation in mammals and how perturbations of these systems result
in human disease. We focus mostly on the mechanism of genomic imprinting mediated by insulators
as is present at the H19/Igf2 locus, and by non-coding RNA present at the Igf2r and Kcnq1 loci. In
addition to imprinting mechanisms at autosomal loci, what is known about imprinted X-chromosome
inactivation and how it compares to autosomal imprinting is also discussed. Overall, this review
summarizes the many years of imprinting research, while pointing out exciting new discoveries that
further elucidate the mechanism of genomic imprinting, and speculating on areas that require further
investigation.
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1.Introduction
The mammalian genome contains a small number of genes that are subject to genomic
imprinting [1,2]. These genes are epigenetically marked with their parental origin such that a
given parental allele is expressed while the other is repressed. While the precise nature of the
initial epigenetic imprint is currently a matter of intense investigation, it is assumed that the
*Corresponding author, Correspondence for manuscript to: Marisa S. Bartolomei, Department of Cell and Developmental Biology,
University of Pennsylvania School of Medicine, 415 Curie Blvd., Philadelphia, PA 19104-6148, Tel. 215-898-9063, Fax 215-573-6434,
Email: bartolom@mail.med.upenn.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest Statement
The authors declare that there are no conflicts of interest
NIH Public Access
Author Manuscript
Mutat Res. Author manuscript; available in PMC 2009 December 1.
Published in final edited form as:













parental imprint is set in the germline, as this is the time when the genomes are in distinct
compartments and can be differentially modified. After fertilization, the parental imprints must
survive the reprogramming that takes place in the preimplantation embryo, including DNA
demethylation, protamine-histone exchange and changes in histone modifications [3]. It is
worth noting that although a number of imprinted genes remain imprinted throughout the life
of the organism, many genes are imprinted in a tissue or temporal-specific way. Finally, while
it is hypothesized that the predominant role of these unusual genes is during fetal and placental
growth and development [4], postnatal roles for some of these imprinted genes are beginning
to be appreciated [5].
Approximately 90 genes have been described as being imprinted, although it is unlikely that
we have identified all imprinted genes (for a complete list, see
http://igc.otago.ac.nz/home.html and
http://www.har.mrc.ac.uk/research/genomic_imprinting/maps.html). One of the hallmarks of
imprinted genes is that many are found in clusters throughout the genome [2]. These clusters
contain two or more imprinted genes over a region that can span 1 Mb or more. The genes in
the clusters, which can be either maternally or paternally expressed, are jointly regulated
through an imprinting control region (ICR). The ICRs exhibit parental-specific epigenetic
modifications (DNA methylation and histone modifications) that govern their activity.
Importantly, deletion of ICRs typically leads to the loss of imprinting of multiple genes within
the cluster (for example see [6–10]). Intriguingly, ICRs can be roughly divided into two
categories, those that function as insulators and those that serve as a promoter for a regulatory
non-coding RNA (ncRNA). Here we will describe clusters that fall into these two major
categories and compare autosomal imprinted clusters to imprinted X-chromosome inactivation.
2. Insulator Model of Imprinting
2.1. H19/Igf2 imprinting
The best-characterized cluster that follows a strict insulator model for imprinted expression is
the cluster containing maternally expressed H19 and paternally expressed insulin-like growth
factor 2 (Igf2) [11,12]. This cluster resides at 11p15.5 in humans and is found in conserved
synteny on distal chromosome 7 in mice. While most studies on H19 and Igf2 have been
performed in the mouse, many attributes of these genes including their expression profile and
regulatory mechanisms are similar in humans. Remarkably Reik and colleagues have recently
shown that the cluster and imprinting are conserved in marsupials, making this imprinting
mechanism the most ancient identified to date [13]. In both mouse and human, H19 and Igf2
are widely expressed during embryonic development and postnatally downregulated in most
tissues. H19 encodes a fully processed 2.3 kb non-coding RNA and was initially implicated as
a tumor suppressor [14,15]. However, it has also been shown to have oncogenic properties
[16–20]. Igf2 encodes a protein that plays a major role in promoting embryonic and placental
growth and development [21]. Both H19 and Igf2 have recently been shown to encode
microRNAs of unknown function [22,23].
As with all imprinted clusters, imprinted expression of H19 and IGF2 is regulated by an ICR
[designated imprinting center 1 (IC1) in humans and ICR or differentially methylated domain
(DMD) in mouse] located between the two genes [24,25]. This region is approximately 5 kb
and 2 kb long in humans and mice, respectively (Figure 1). It acts by regulating interactions
between the H19 and IGF2 promoters and their shared enhancers, which lie downstream of
H19 (Figure 1). Deletion of the ICR/DMD results in loss of imprinting (LOI) at H19 and
Igf2 [8]. Proper imprinting of H19 and Igf2 requires that the ICR/DMD is methylated on the
paternal allele and unmethylated on the maternal allele. Mutations in CpGs at the ICR/DMD
result in hypomethylation and subsequent biallelic expression of H19 and downregulation of
Igf2 [26].
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An important breakthrough in determining the imprinting mechanism at this locus came from
the characterization of conserved sequences at the mouse and human ICRs [27,28]. When
unmethylated, these sequences bind to the insulator protein CCCTC-binding factor (CTCF)
[29–33](Figure 1A). CTCF was initially shown to mediate insulator or enhancer blocking
activity at similar sequences in the β-globin locus [34]. The current model of imprinting
regulation at the H19/Igf2 locus is that binding of CTCF to the unmethylated maternal ICR/
DMD protects it from de novo methylation and prevents downstream enhancers from activating
Igf2, leaving them available to activate transcription at H19 (Figure 1A). CTCF is unable to
bind the methylated paternal ICR/DMD resulting in expression of Igf2 while H19 is silenced.
Targeted mutation of CTCF sites demonstrated that these sites are necessary for imprint
maintenance but not establishment [35–38].
Although it is now well established that the ICR/DMD acts as a CTCF-dependent insulator/
enhancer blocker, the mechanism of insulation remains incomplete. Chromosome
conformation capture (3C) experiments in mice, which assay for physical interactions between
chromosomal regions, have suggested that chromosomal looping is involved in the imprinting
mechanism, although the precise nature and function of the looping is debated [39–43]. While
there is some consensus that the shared enhancers physically interact with the Igf2 promoters
on the paternal chromosome, interactions on the maternal chromosome remain unclear.
Karukuti et al report that maternal-specific silencing of Igf2 results when the ICR/DMD
interacts with a matrix attachment region and a differentially methylated region at the Igf2
locus to generate a tight loop around the Igf2 gene, thereby physically impeding Igf2 expression
[40]. In contrast, Yoon and colleagues demonstrate that the ICR/DMD forms a transcriptionally
unproductive association with enhancers and the inactive Igf2 promoters on the maternal
chromosome, which leads to silencing of Igf2 [43]. It is unclear how this “decoy” type of model
would allow for the interaction between the enhancers and the H19 promoter, which are
necessary for maternal H19 expression. More recently, we have shown that on the maternal
allele, the enhancers make contacts throughout the H19 coding unit and promoter up to, but
not beyond, the ICR/DMD [39]. When the ICR/DMD or CTCF binding sites are deleted on
the maternal allele, the enhancers interact throughout the locus, suggesting that the enhancers
track along the chromosome until they find a suitable promoter sequence and then the insulator
blocks further tracking. There are several reasons why these 3C experiments produce differing
results and models. First, the assays were designed to test different interactions (enhancers
versus ICR/DMD interactions). Second, different restriction enzymes were used to digest the
DNA, which may not have separated regulatory sequences adequately. Third, cells and tissues
that were analyzed varied. Finally, the assays were not performed across the entire H19/Igf2
domain in all of the studies and could not be considered highly quantitative. Thus, it is difficult
to discern the correctness of one model versus another. Nevertheless, the examination of
multiple ICR/DMD mutant alleles demonstrates that long-range allele-specific interactions at
the H19/Igf2 locus are dependent upon the ICR/DMD.
Regardless of the precise mechanism of insulator activity, it is clear that distal elements interact.
Consistent with the notion of these interactions, recent studies have demonstrated that cohesins,
which physically connect sister chromatids, colocalize with CTCF [44,45]. In particular, two
cohesin proteins, RAD21 and SMC1, associate with CTCF sites at the H19/Igf2 DMD in an
allele-specific manner that is comparable to CTCF binding [46], however it remains unknown
whether cohesin binding is required for CTCF association or vice versa. Further studies to
determine the timing of binding of cohesin or additional factors at the ICR/DMD as it relates
to imprint establishment in the germline and maintenance throughout development will provide
important clues in elucidating the molecular mechanism of H19/Igf2 imprinting.
Ideraabdullah et al. Page 3













2.2. H19/Igf2 and disease
LOI and/or aberrant expression of H19 and IGF2 is associated with somatic overgrowth and
embryonal tumors and has been linked to more than 20 cancer types in human including Wilms’
tumor and colorectal, lung, breast and prostate cancers [47]. In addition, the overgrowth
disorder Beckwith-Weidemann Syndrome (BWS) and the dwarfism syndrome Silver-Russell
Syndrome (SRS) are strongly associated with defects in H19/IGF2 imprinting [48,49].
Although the precise physiological role of H19 and IGF2 in the development of these diseases
is unclear, we are starting to appreciate how epigenetic perturbations of the locus can lead to
LOI. Analysis of BWS patients revealed that hypermethylation of the IC1, leading to LOI at
H19 and IGF2, can result from either maternally inherited deletions in the IC1 or post-
zygotically acquired sporadic epimutations that are IC1 sequence-independent and present
mosaically [50]. Likewise, analysis of SRS patients revealed that hypomethylation of IC1 can
arise independently of changes in the IC1 sequence [51].
In a recent human study, 1.4 kb to 1.8 kb microdeletions at the H19/IGF2 ICR were shown to
result in H19/IGF2 LOI and were associated with BWS [52,53] (Figure 1B). However, in a
separate study, a 2.2 kb IC1 deletion was insufficient to cause BWS [54,55] (Figure 1B). This
discrepancy was proposed to result from a difference in spacing/pattern of remaining CTCF
sites. The shorter mutations deleted fewer sites resulting in abnormally long clusters of CTCF
sites (and CpGs), all of which became aberrantly methylated on the maternal allele. On the
other hand, the larger deletion resulted in a cluster of CTCF sites similar to one of the two
clusters present on the normal allele. Therefore, the bipartite spacing/pattern of CTCF sites
may play a role in determining the epigenetic status of the ICR. Alternatively, the two types
of deletions may result in different perturbations of additional regulatory elements such as
transcripts that have been described at the ICR/DMD in mice [56] or nucleosome positioning
sites (NPSs) present in the intervening sequence that have been proposed to regulate CTCF
site availability [57]. Needless to say, further scrutiny of the H19/Igf2 ICR/DMD is necessary
to definitively characterize its regulatory function in genomic imprinting.
3. Non-coding RNA model of Imprinting
3.1 Overview
The majority of imprinted loci appear to use a second, ncRNA mechanism of regulation of
imprinting in clusters (Figure 2). The first, and perhaps the best described, cluster in this class
is the Igf2r cluster, which resides on mouse chromosome 17A [58] (Figure 2A). Igf2r and two
neighboring genes, Slc22a2 and Slc22a3 (solute carrier 22a2 and 22a3), are expressed
maternally. This region also harbors one paternally-expressed transcript, Air (antisense Igf2r
RNA) that overlaps Igf2r and whose expression is critical to the silencing of the maternally-
expressed genes in cis [59]. Furthermore, similar to other imprinted domains, Air expression
is regulated by an ICR with parental-specific epigenetic modifications [60]. However, in
contrast to other imprinted loci, the genomic organization and the imprinting pattern of the
Igf2r cluster are only partially conserved in the human syntenic region, on chromosome 6q26–
27.
Other loci that express long ncRNAs that are likely to be involved in the imprinting process
include the Gnas locus [61], the Dlk1/Gtl2 locus [62] and the Snrpn locus [2]. The reader is
referred to the excellent reviews for more details of the above loci. Here, we will focus on the
Kcnq1 locus. Although the Kcnq1 locus is immediately adjacent to the H19/Igf2 locus in both
mouse and human, it is independently regulated. Importantly, much of what we know about
the Kcnq1 locus is conserved in human [63]. In addition, over half of the documented BWS
cases are associated with defects in imprinted gene expression in the KCNQ1 domain. The
majority of these BWS cases exhibit a loss of maternal-specific DNA methylation of the ICR,
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designated KvDMR1, and subsequent loss of expression of the maternally expressed genes.
Also, mutations in the maternally expressed cell-cycle regulator cyclin dependent kinase
inhibitor, CDKN1C, constitute about 10% of BWS cases [64].
3.2 ncRNA and the Kcnq1 locus
The Kcnq1 locus contains one paternally-expressed gene encoding a long (>60 kb) ncRNA,
Kcnq1ot1, and at least 8 maternally-expressed protein-coding genes, including Cdkn1c,
Mash2, Phlda2 [63] (Figure 2B). The locus (and the ncRNA, in particular) is governed by the
maternally-methylated ICR, KvDMR1, which is located within an intron of the Kcnq1 gene
[65–67]. The promoter for the Kcnq1ot1 gene resides within KvDMR1. Hypomethylation of
the promoter on the paternal allele is associated with Kcnq1ot1 expression and repression of
the adjacent protein-coding imprinted genes, whereas hypermethylation of KvDMR1 on the
maternal allele is associated with repression of the ncRNA and activation of the adjacent
imprinted genes. Deletion of KvDMR1 on the paternal allele results in a failure to express
Kcnq1ot1 and in biallelic expression of the genes that are normally only expressed on the
maternal allele [6,68], suggesting that transcription of the ncRNA Kcnq1ot1 is essential to
silence the 8 protein coding genes in cis. Furthermore, insertion of a transcriptional stop signal
downstream of the promoter on the paternal allele results in the activation of the normally
silenced genes on that allele [68]. Thus, similar to what has been reported for the Igf2r/Air
locus, transcription of Kcnq1ot1 or the transcript itself is required for bidirectional repression
of genes in cis.
More recently, a new Kcnq1ot truncation allele reported by Higgins and colleagues confirmed
that absence of the full length Kcnq1ot transcript resulted in loss of imprinting of the linked
genes, with one notable exception. In the embryo proper, Cdkn1c was still imprinted in a subset
of tissues [69]. This study demonstrated that Cdkn1c imprinting can be regulated by a
mechanism independent of the Kcnqt1ot1 ncRNA. Given that deletion of KvDMR1 results in
loss of imprinting of Cdkn1c in all tissues [6], the ncRNA-independent mechanism may rely
on element(s) within KvDMR1. As such, two CTCF binding sites within KvDMR1 have been
identified that are occupied in vivo only on the unmethylated paternal allele [70]. Thus, it is
possible that for a gene as important to the growth of the embryo as Cdkn1c, redundant
mechanisms are in place to assure its appropriate imprinting and consequently, its dosage.
Although a role for long ncRNAs appears certain at autosomal imprinted loci, as well as in X-
chromosome inactivation (see below), it is still unclear how these RNAs silence overlapping
and nonoverlapping genes that are located in cis. Additionally, while some of these silenced
genes are several hundred kilobase pairs away, in some loci, such as Igf2r, genes more proximal
escape the silencing. Multiple models have been proposed to address this complex regulation
[2,71]. First, an RNAi based model is suggested in which the long antisense ncRNA forms a
double-stranded RNA intermediate complementary to the silenced gene, which then triggers
silencing by one of the strategies documented in other systems, including RNA degradation,
translational repression or heterochromatin formation [72]. The major problem with this model,
however, is that it cannot explain silencing of nonoverlapping genes with no sequence
similarity, nor can it account for silencing in cis. A second possible mechanism invokes an
Xist type model of silencing, in which the Xist RNA coats the inactive X-chromosome (see
below). The silencing in this case would be much more limited (that is, not coating an entire
chromosome), and although coating of the imprinted silenced domains by ncRNA has not yet
been reported, such a mechanism cannot be discounted. Finally, models invoking silencing by
transcription through the locus have been proposed. In this case, it is the transcription rather
than the product of transcription that is important for silencing. Here, transcription could
interfere with activators or activate repressors. This particular class of models requires the
identity of cis-acting regulatory elements, which remain unknown for most imprinted domains.
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4. Imprinted X inactivation
An additional type of imprinting is found on the sex chromosomes in the form of dosage
compensation. In mammals, dosage compensation of the X-chromosomes between females
(XX) and males (XY) is achieved through X-chromosome inactivation (XCI), a process by
which one of the two X-chromosomes in females is transcriptionally silenced and the inactive
state is clonally transmitted throughout cell divisions [73]. In the postimplantation embryo,
either the maternal or the paternal X-chromosome is inactivated, which is referred to as random
XCI [74], whereas in the preimplantation embryo and in the extraembryonic lineages, XCI is
imprinted with only the paternal X-chromosome (Xp) being silenced [75–79]. Random and
imprinted XCI are controlled by a region of the X-chromosome, designated the X-chromosome
inactivation center (XIC). The most notable components of the XIC are the Xist and Tsix genes,
which encode long ncRNAs [80]. High expression of Xist is generally associated with cis-
inactivation, whereas Tsix is only expressed from the active X-chromosome. Thus, the strategy
for using long ncRNA to silence genes in cis, as observed for a subset of autosomal imprinted
loci, is also invoked here. However, as described below Xist coats the chromosome that it
inactivates, a process that has not yet been observed at autosomal imprinted loci.
In mice, Xist coating is first observed at the 2-cell or 4-cell embryonic stages [75,77]. Other
epigenetic marks are progressively recruited on the Xp between the 2-cell and the blastocyst
stage, which subsequently leads to X-linked genes becoming silenced in cis [75–77,81,82]
(Figure 3). Random XCI occurs after reactivation of the Xp in the inner cell mass of the
blastocyst, whereas the inactive Xp is maintained in the trophoblastic and the primitive
endoderm cell lineages [74]. The correlation between cell-specific marks on the inactive X-
chromosome, as well as their sequential acquisition and loss during development, suggest that
yet unknown connections exist between cell lineage determination and XCI.
A maternal imprint, protecting the maternal X-chromosome (Xm) from XCI, is acquired during
oocyte maturation [83–85]. The paternal imprint, prompting the Xp to inactivation, is
apparently weaker [86,87]. It is regulated by the XIC, as revealed by the ability of an autosomal
transgene of the XIC to recapitulate imprinted cis-inactivation when it is paternally, but not
maternally, inherited [88]. However, the mechanism responsible for the imprint in XCI remains
to be elucidated.
The requirement of the Xist RNA for the initiation of random XCI and for imprinted XCI in
the extraembryonic lineages is well documented [89,90], but has yet to be demonstrated for
the establishment of imprinted XCI in the preimplantation embryo. In addition to Xist,
maintenance of the inactive state of the Xp requires the Polycomb protein, EED, likely through
the trimethylation of H3K27, in the trophoblastic but not in the primitive endoderm lineage
[91,92]. DNA methylation at the 5' end of genes is important for the stability of random XCI
in the embryo proper, but the methylation pattern of the genes and the requirement for DNA
methylation are less clear in extraembryonic tissues [74]. Inactivation of the Xp is not affected
in the visceral endoderm of mice lacking the DNA methyltransferase DNMT1 [93] but seems
to be altered in trophoblast cells mutated for the newly characterized SmcHD1 (structural
maintenance of chromosomes hinge domain containing 1) gene [94]. Together, these results
suggest that imprinted XCI does not rely on DNA methylation in the same manner as autosomal
imprinted genes.
Tsix represses Xist expression in several cell types [80] and its continuous expression on the
maternal X chromosome (Xm) is required in extraembryonic lineages to prevent cis-expression
of Xist and cis-inactivation [95,96]. However, it is unlikely that Tsix propagates the maternal
imprint in the preimplantation embryo, because its expression is detected only in a minority of
cells before the blastocyst stage [97]. Tsix major promoter lies close to the DXPas34 34mer
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repeat, a regulator of Tsix expression [97–102], features of which are reminiscent of ICRs:
differential methylation between male and female, though only after implantation [103],
binding of CTCF and Yin Yang 1 (YY1) [104–106], and initiation of bidirectional transcription
[99]. Differential methylation between sperm and oocyte is not found at DXPas34 but is present
at a few CTCF binding sites close to it, which were proposed to carry the imprint for XCI
[103,107]. In addition, DXPas34 or sequences nearby seem important for keeping the Xm
active in extraembryonic lineages [99], possibly through the regulation of Tsix expression.
Other CTCF and YY1 binding sites have been characterized in the XIC, notably in the Xist
promoter region [106,108,109]. As inter-chromosomal and intra-chromosomal interactions, as
well as nuclear localization play a role in random XCI [109–114], it will be interesting to see
if it is also the case during imprinted XCI and if it involves CTCF.
Random XCI is found in several eutherian species, including human, but less is known about
imprinted XCI. In addition to mouse, imprinted XCI is found in the bovine placenta [115]. In
marsupials, imprinted XCI of the Xp was reported both in extraembryonic and somatic tissues
[116–118] but the degree of silencing of certain genes vary between individuals and cell types,
and during development [119,120]. On the Xp, histones are hypoacetylated but promoters are
not methylated [121,122]. Furthermore, Xist is poorly conserved and its orthologue, Lnx3,
encodes a protein, thus it is unlikely to participate in XCI [123]. However, meiotic sex
chromosome inactivation during spermatogenesis in marsupials is more stable than in
eutherians and could be an alternative way to initiate XCI [124,125]. If so, imprinted XCI may
have evolved independently in eutherians and marsupials, or eutherians could have developed
new mechanisms to initiate XCI in the early embryo from a template mechanism still used in
marsupials [126].
In human, it is not clear whether the Xp is preferentially inactivated in extraembryonic tissues
[127]. In addition, XIST seems to be biallelically expressed from the 2-cell to the blastocyst
stage, arguing against imprinted XCI [128,129]. Contrary to mouse, TSIX transcripts in human
overlap with only part of the XIST gene, which may result in the inability to repress XIST in
cis [130]. Finally, human XmXmXp females and XmXmY males have less severe
developmental defects than their mouse counterparts [131], suggesting that a strong maternal
imprint does not exist. Taken together, these observations make the existence of imprinted XCI
unlikely in humans. Thus, in contrast to autosomal imprinted genes, where imprinting is widely
conserved, imprinted XCI appears species-specific.
5. Conclusions and Future Directions
In the past decade much has been learned with respect to the identity of imprinted genes,
imprinting control regions, the epigenetic modifications characteristic of this unusual class of
genes and the role that insulators and ncRNAs play in mediating imprinting across large
clusters. Nevertheless, our knowledge of how insulators and long ncRNAs work at these loci
is rudimentary and a lot remains to be learned. For example, how do ncRNAs silence non-
overlapping genes? What role do cohesins play, if any, in the regulation of insulators?
Furthermore, not every large cluster of imprinted genes falls into one of the two distinct
categories described in this review. An example of this was described above for the Kcnq1
locus, where Cdkn1c is not solely regulated by expression of the ncRNA Kcnqt1ot1. Here, it
is possible that Cdkn1c imprinting is also regulated by a CTCF-dependent insulator.
Finally, it is likely that other undiscovered paradigms for imprinting regulation exist. The
Dlk1/Gtl2 locus provides one such example. A paternally-methylated germline ICR,
designated IG-DMR1, is a few kilobase pairs upstream from the start of Gtl2 transcription at
this locus. When this ICR is deleted, the expression on the maternal allele is disrupted but the
paternal allele exhibits normal imprinting [7]. It is presently unclear how this allele regulated.
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An additional example comes from a recent report by Wood and colleagues where allele-
specific differences in a co-transcriptional process were described [132]. In this study the newly
identified H13 imprinted gene was shown to use alternate polyadenylation (polyA) signals to
govern allele-specific expression of alternate transcripts. The choice of polyA sites was dictated
by allele-specific methylation of a CpG island located between the sites, with DNA methylation
of the island repressing the use of the adjacent set of polyA signals and the readthrough to the
downstream polyA signals. Thus, it seems reasonable to predict that other such intriguing
regulatory processes will emerge in the study of imprinted genes.
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Regulation of imprinted expression at the human and mouse H19/Igf2 loci. Shown is the
organization of the mouse (top) and human (bottom) locus (not drawn to scale). Genomic
positions in base pairs based on NCBI build 36 (humans) and 37 (mouse). CTCF target sites
(designated as CTSs in human and shown with black bars) are indicated within the ICR/DMD/
IC1 (yellow bar). (A) Methylation status and gene expression are shown for the mouse H19/
Igf2 locus. Arrows at genes denote active status while arrows pointing right to left denote
interactions between enhancers and gene promoters. (B) Microdeletions at IC1 in BWS patients
are denoted by hatched-marked bars (modified from [133]). See text for references. The CTSs
that are deleted in each case are represented in parenthesis beside each deletion. The
corresponding methylation status of the maternally inherited allele for each deletion is depicted
to the right as unmethylated (open lollipops), methylated (filled lollipops) or partially
methylated (half-filled lollipops).
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Regulation of imprinting clusters through long ncRNAs. (A) Imprinting on proximal mouse
chromosome 17. Igf2r, Slc22a2 and Slc22a3 are expressed from the maternal chromosome
(pink boxes) and Air is expressed from the paternal chromosome (blue arrow). Non-imprinted
genes at this domain include Mas1, Plg and Slc22a1 (grey boxes). The ICR, which serves as
the promoter to Air, is shown with a yellow box. The ICR is hypermethylated on the maternal
strand, preventing transcription of Air and allowing Igf2r, Slc22a2 and Slc22a3 to be
transcribed. On the paternal chromosome the ICR is unmethylated, Air is expressed and
surrounding genes (Igf2r, Slc22a2 and Slc22a3) are repressed (indicated with a dotted arrow).
(B) Imprinting of the mouse Kcnq1 domain. Maternally-expressed genes are indicated by pink
boxes and the paternally-expressed long ncRNA Kcnq1ot1 is shown with a blue arrow.
KvDMR1, which is the ICR for this region and harbors the promoter for Kcnq1ot1, is
designated by a yellow box and is methylated on the maternal allele. The promoter for
Cdkn1c is methylated on the paternal allele after fertilization. The two CTCF binding sites
within KvDMR1 are designated with vertical arrows. See text for additional details.
Transcriptional activity of a given gene is indicated by arrows. Not drawn to scale.
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Kinetics of X-chromosome inactivation during development in mice. Stages after zygotic
genome activation are represented together with a schematic view of the XCI pattern. Xist
domain is depicted by a green oval. Xist, Tsix and X-linked genes expression are depicted by
green, yellow and red dots, respectively. (A) Acquisition of a maternal imprint during oocyte
growth and of a paternal imprint either during spermatogenesis or early after fertilization. (B)
Establishment of imprinted X-chromosome inactivation (XCI). The marks on the paternal Xp
are indicated along the arrow to reflect when they start to be acquired. Cot-1 exclusion refers
to the absence of labelling of essentially intergenic transcripts by RNA fluorescence in situ
hybridization using a Cot-1 probe. Whether the X-chromosome is preinactivated at the 2-cell
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stage is unresolved [75,77]. Tsix RNA is present in a fraction of cells in E3.5 blastocysts but
it is not known if the expression is equivalent in the trophectoderm and the ICM. (C)
Reactivation and random XCI in the embryonic lineage (blue). In the ICM of E4.5 blastocysts
and in ES cells, which are derived from the ICM, the Xist domain and the heterochromatin
marks on the Xp are lost and Xist and Tsix are expressed biallelically. However, Xist expression
is very low and hence not represented here (Sun et al., 2006). In the epiblast after E5.5 and in
differentiated ES cells, either the paternal or the maternal X-chromosome is inactivated due to
random XCI. Known heterochromatin marks associated with the inactive X-chromosome are
indicated. (D) Maintenance of imprinted XCI in the trophoblast (light red) and primitive
endoderm (yellow) lineages. In the trophoblast lineage, the imprinted pattern of XCI is
maintained without interruption. Tsix expression in the trophoblast lineage at E6.5 is inferred
from its expression pattern at earlier and later stages and from its requirement on Xm early
after implantation. In the primitive endoderm lineage, XCI is imprinted, but it is not known if
the Xp is continuously inactive or if it is transiently reactivated when the primitive endoderm
differentiates from the ICM (green question mark). Also, Tsix pattern of expression has not
been reported in the primitive endoderm lineage (yellow question mark). Known marks on the
Xp are indicated for TS cells [81,91,134,135] and XEN cells [91,136], which are cell models
of the trophectoderm and the visceral endoderm, respectively. See text for additional
references. Xp, paternal X-chromosome; Xm, maternal X-chromosome; ICM, inner cell mass;
TE, trophectoderm; EPI, epiblast; EC, ectoplacental cone; EE, extraembryonic ectoderm; ES
cells, embryonic stem cells; TS cells, trophoblast stem cells; XEN cells,
extraembryonicextraembryonic stem cells; PRC1, Polycomb-Repressive Complex 1; PRC2,
Polycomb-Repressive Complex 2.
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